TFS CEO featured in Pharma Boardroom
Focus on Sweden report published by Pharma Boardroom features János Filakovský, TFS Chief Executive Officer, discussing TFS unique capabilities and analyzing the Swedish life sciences industry’s potential to become the leader in e-health and new treatments. TFS, as provider of clinical development solutions to biopharmaceutical companies, serves global clinical trial markets with local expertise and worldwide project delivery. Full interview with János Filakovský is available here.
The report provides a deep analysis of the market and the clinical research industry "Sweden has opted to play to its strengths and take advantage of its highly-skilled workforce, quality registries, fully digitalized population, decades of expertise, and changing dynamics in the pharmaceutical industry to develop into a contract research organization (CRO) hub." The report is available to subscribers of pharmaboardroom.com